Einat Frydman is responsible for Ferring US product supply operations.
Einat is an executive with 25 years of pharmaceutical, medical device, biotechnology and life science operations experience, including early-stage, pre-commercial start-up, and commercial manufacturing. Her management experience includes API & Sterile FP manufacturing, materials, engineering, facilities, EH&S, process development, commercial development, validation, distribution and cost modeling. She also has extensive experience in quality manufacturing and quality operations. Prior to assuming her current role, Einat was General Manager of Bio-Technology General (Israel) Ltd., a Ferring Group company and manufacturer of EUFLEXXA® (1% sodium hyaluronate). Before joining Ferring, she spent 18 years with Teva Pharmaceuticals in a variety of positions of increasing responsibility, such as Head of Regulatory Compliance and Head of Quality Assurance, and finally as Executive Director of the sterile manufacturing plant in Israel producing 40 M sterile units for 40 destinations around the world.
Einat holds a Bachelor of Science in Chemical Engineering from Technion – Israel Institute of Technology.